What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Buy
56
FHLC Quote, Financials, Valuation and Earnings
Last price:
$63.56
Seasonality move
:
4.4%
Day range:
$62.76 - $63.73
52-week range:
$60.35 - $74.48
Dividend yield:
1.6%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
187.9K
Avg. volume:
179.7K
1-year change:
-8.17%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
FHLC
Fidelity MSCI Health Care Index ETF
|
$63.58 | -- | -- | -- | $0.26 | 1.6% | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
$162.05 | -- | -- | -- | $1.17 | 0.72% | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
$64.37 | -- | -- | -- | $0.13 | 0.26% | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
$80.93 | -- | -- | -- | $0.27 | 1.19% | -- |
|
XBI
SPDR S&P Biotech ETF
|
$82.38 | -- | -- | -- | $0.01 | 0.17% | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
$132.60 | -- | -- | -- | $0.56 | 1.76% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | 0.549 | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | 0.751 | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | 0.936 | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | 0.292 | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | 0.979 | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | 0.443 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
FHLC
Fidelity MSCI Health Care Index ETF
|
-- | -- | -- | -- | -- | -- |
|
FBT
First Trust NYSE Arca Biotechnology Index Fund
|
-- | -- | -- | -- | -- | -- |
|
PBE
Invesco Biotechnology & Genome ETF
|
-- | -- | -- | -- | -- | -- |
|
PJP
Invesco Pharmaceuticals ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
|
XLV
Health Care Select Sector SPDR Fund
|
-- | -- | -- | -- | -- | -- |
Fidelity MSCI Health Care Index ETF vs. Competitors
-
Which has Higher Returns FHLC or FBT?
First Trust NYSE Arca Biotechnology Index Fund has a net margin of -- compared to Fidelity MSCI Health Care Index ETF's net margin of --. Fidelity MSCI Health Care Index ETF's return on equity of -- beat First Trust NYSE Arca Biotechnology Index Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FHLCFidelity MSCI Health Care Index ETF-- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- -
What do Analysts Say About FHLC or FBT?
Fidelity MSCI Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand First Trust NYSE Arca Biotechnology Index Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity MSCI Health Care Index ETF has higher upside potential than First Trust NYSE Arca Biotechnology Index Fund, analysts believe Fidelity MSCI Health Care Index ETF is more attractive than First Trust NYSE Arca Biotechnology Index Fund.
Company Buy Ratings Hold Ratings Sell Ratings FHLCFidelity MSCI Health Care Index ETF0 0 0 FBTFirst Trust NYSE Arca Biotechnology Index Fund0 0 0 -
Is FHLC or FBT More Risky?
Fidelity MSCI Health Care Index ETF has a beta of 0.685, which suggesting that the stock is 31.505% less volatile than S&P 500. In comparison First Trust NYSE Arca Biotechnology Index Fund has a beta of 0.647, suggesting its less volatile than the S&P 500 by 35.317%.
-
Which is a Better Dividend Stock FHLC or FBT?
Fidelity MSCI Health Care Index ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 1.6%. First Trust NYSE Arca Biotechnology Index Fund offers a yield of 0.72% to investors and pays a quarterly dividend of $1.17 per share. Fidelity MSCI Health Care Index ETF pays -- of its earnings as a dividend. First Trust NYSE Arca Biotechnology Index Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FHLC or FBT?
Fidelity MSCI Health Care Index ETF quarterly revenues are --, which are smaller than First Trust NYSE Arca Biotechnology Index Fund quarterly revenues of --. Fidelity MSCI Health Care Index ETF's net income of -- is lower than First Trust NYSE Arca Biotechnology Index Fund's net income of --. Notably, Fidelity MSCI Health Care Index ETF's price-to-earnings ratio is -- while First Trust NYSE Arca Biotechnology Index Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity MSCI Health Care Index ETF is -- versus -- for First Trust NYSE Arca Biotechnology Index Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FHLCFidelity MSCI Health Care Index ETF-- -- -- -- FBTFirst Trust NYSE Arca Biotechnology Index Fund-- -- -- --
-
Which has Higher Returns FHLC or PBE?
Invesco Biotechnology & Genome ETF has a net margin of -- compared to Fidelity MSCI Health Care Index ETF's net margin of --. Fidelity MSCI Health Care Index ETF's return on equity of -- beat Invesco Biotechnology & Genome ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FHLCFidelity MSCI Health Care Index ETF-- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- -
What do Analysts Say About FHLC or PBE?
Fidelity MSCI Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Biotechnology & Genome ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity MSCI Health Care Index ETF has higher upside potential than Invesco Biotechnology & Genome ETF, analysts believe Fidelity MSCI Health Care Index ETF is more attractive than Invesco Biotechnology & Genome ETF.
Company Buy Ratings Hold Ratings Sell Ratings FHLCFidelity MSCI Health Care Index ETF0 0 0 PBEInvesco Biotechnology & Genome ETF0 0 0 -
Is FHLC or PBE More Risky?
Fidelity MSCI Health Care Index ETF has a beta of 0.685, which suggesting that the stock is 31.505% less volatile than S&P 500. In comparison Invesco Biotechnology & Genome ETF has a beta of 0.809, suggesting its less volatile than the S&P 500 by 19.078%.
-
Which is a Better Dividend Stock FHLC or PBE?
Fidelity MSCI Health Care Index ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 1.6%. Invesco Biotechnology & Genome ETF offers a yield of 0.26% to investors and pays a quarterly dividend of $0.13 per share. Fidelity MSCI Health Care Index ETF pays -- of its earnings as a dividend. Invesco Biotechnology & Genome ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FHLC or PBE?
Fidelity MSCI Health Care Index ETF quarterly revenues are --, which are smaller than Invesco Biotechnology & Genome ETF quarterly revenues of --. Fidelity MSCI Health Care Index ETF's net income of -- is lower than Invesco Biotechnology & Genome ETF's net income of --. Notably, Fidelity MSCI Health Care Index ETF's price-to-earnings ratio is -- while Invesco Biotechnology & Genome ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity MSCI Health Care Index ETF is -- versus -- for Invesco Biotechnology & Genome ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FHLCFidelity MSCI Health Care Index ETF-- -- -- -- PBEInvesco Biotechnology & Genome ETF-- -- -- --
-
Which has Higher Returns FHLC or PJP?
Invesco Pharmaceuticals ETF has a net margin of -- compared to Fidelity MSCI Health Care Index ETF's net margin of --. Fidelity MSCI Health Care Index ETF's return on equity of -- beat Invesco Pharmaceuticals ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FHLCFidelity MSCI Health Care Index ETF-- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- -
What do Analysts Say About FHLC or PJP?
Fidelity MSCI Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Pharmaceuticals ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity MSCI Health Care Index ETF has higher upside potential than Invesco Pharmaceuticals ETF, analysts believe Fidelity MSCI Health Care Index ETF is more attractive than Invesco Pharmaceuticals ETF.
Company Buy Ratings Hold Ratings Sell Ratings FHLCFidelity MSCI Health Care Index ETF0 0 0 PJPInvesco Pharmaceuticals ETF0 0 0 -
Is FHLC or PJP More Risky?
Fidelity MSCI Health Care Index ETF has a beta of 0.685, which suggesting that the stock is 31.505% less volatile than S&P 500. In comparison Invesco Pharmaceuticals ETF has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.427%.
-
Which is a Better Dividend Stock FHLC or PJP?
Fidelity MSCI Health Care Index ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 1.6%. Invesco Pharmaceuticals ETF offers a yield of 1.19% to investors and pays a quarterly dividend of $0.27 per share. Fidelity MSCI Health Care Index ETF pays -- of its earnings as a dividend. Invesco Pharmaceuticals ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FHLC or PJP?
Fidelity MSCI Health Care Index ETF quarterly revenues are --, which are smaller than Invesco Pharmaceuticals ETF quarterly revenues of --. Fidelity MSCI Health Care Index ETF's net income of -- is lower than Invesco Pharmaceuticals ETF's net income of --. Notably, Fidelity MSCI Health Care Index ETF's price-to-earnings ratio is -- while Invesco Pharmaceuticals ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity MSCI Health Care Index ETF is -- versus -- for Invesco Pharmaceuticals ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FHLCFidelity MSCI Health Care Index ETF-- -- -- -- PJPInvesco Pharmaceuticals ETF-- -- -- --
-
Which has Higher Returns FHLC or XBI?
SPDR S&P Biotech ETF has a net margin of -- compared to Fidelity MSCI Health Care Index ETF's net margin of --. Fidelity MSCI Health Care Index ETF's return on equity of -- beat SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FHLCFidelity MSCI Health Care Index ETF-- -- -- XBISPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About FHLC or XBI?
Fidelity MSCI Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity MSCI Health Care Index ETF has higher upside potential than SPDR S&P Biotech ETF, analysts believe Fidelity MSCI Health Care Index ETF is more attractive than SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings FHLCFidelity MSCI Health Care Index ETF0 0 0 XBISPDR S&P Biotech ETF0 0 0 -
Is FHLC or XBI More Risky?
Fidelity MSCI Health Care Index ETF has a beta of 0.685, which suggesting that the stock is 31.505% less volatile than S&P 500. In comparison SPDR S&P Biotech ETF has a beta of 0.919, suggesting its less volatile than the S&P 500 by 8.063%.
-
Which is a Better Dividend Stock FHLC or XBI?
Fidelity MSCI Health Care Index ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 1.6%. SPDR S&P Biotech ETF offers a yield of 0.17% to investors and pays a quarterly dividend of $0.01 per share. Fidelity MSCI Health Care Index ETF pays -- of its earnings as a dividend. SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FHLC or XBI?
Fidelity MSCI Health Care Index ETF quarterly revenues are --, which are smaller than SPDR S&P Biotech ETF quarterly revenues of --. Fidelity MSCI Health Care Index ETF's net income of -- is lower than SPDR S&P Biotech ETF's net income of --. Notably, Fidelity MSCI Health Care Index ETF's price-to-earnings ratio is -- while SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity MSCI Health Care Index ETF is -- versus -- for SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FHLCFidelity MSCI Health Care Index ETF-- -- -- -- XBISPDR S&P Biotech ETF-- -- -- --
-
Which has Higher Returns FHLC or XLV?
Health Care Select Sector SPDR Fund has a net margin of -- compared to Fidelity MSCI Health Care Index ETF's net margin of --. Fidelity MSCI Health Care Index ETF's return on equity of -- beat Health Care Select Sector SPDR Fund's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital FHLCFidelity MSCI Health Care Index ETF-- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- -
What do Analysts Say About FHLC or XLV?
Fidelity MSCI Health Care Index ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Health Care Select Sector SPDR Fund has an analysts' consensus of -- which suggests that it could fall by --. Given that Fidelity MSCI Health Care Index ETF has higher upside potential than Health Care Select Sector SPDR Fund, analysts believe Fidelity MSCI Health Care Index ETF is more attractive than Health Care Select Sector SPDR Fund.
Company Buy Ratings Hold Ratings Sell Ratings FHLCFidelity MSCI Health Care Index ETF0 0 0 XLVHealth Care Select Sector SPDR Fund0 0 0 -
Is FHLC or XLV More Risky?
Fidelity MSCI Health Care Index ETF has a beta of 0.685, which suggesting that the stock is 31.505% less volatile than S&P 500. In comparison Health Care Select Sector SPDR Fund has a beta of 0.654, suggesting its less volatile than the S&P 500 by 34.588%.
-
Which is a Better Dividend Stock FHLC or XLV?
Fidelity MSCI Health Care Index ETF has a quarterly dividend of $0.26 per share corresponding to a yield of 1.6%. Health Care Select Sector SPDR Fund offers a yield of 1.76% to investors and pays a quarterly dividend of $0.56 per share. Fidelity MSCI Health Care Index ETF pays -- of its earnings as a dividend. Health Care Select Sector SPDR Fund pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios FHLC or XLV?
Fidelity MSCI Health Care Index ETF quarterly revenues are --, which are smaller than Health Care Select Sector SPDR Fund quarterly revenues of --. Fidelity MSCI Health Care Index ETF's net income of -- is lower than Health Care Select Sector SPDR Fund's net income of --. Notably, Fidelity MSCI Health Care Index ETF's price-to-earnings ratio is -- while Health Care Select Sector SPDR Fund's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fidelity MSCI Health Care Index ETF is -- versus -- for Health Care Select Sector SPDR Fund. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income FHLCFidelity MSCI Health Care Index ETF-- -- -- -- XLVHealth Care Select Sector SPDR Fund-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
60
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
58
AMBA alert for Jun 25
Ambarella [AMBA] is up 4.36% over the past day.
Buy
65
EXOD alert for Jun 25
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
